Operating companyOther Health Care

Protego Biopharma, Inc.

San Diego, CA

$85.0M

sold in all offerings

Protego Biopharma, Inc. is a corporation based in San Diego, CA in the Other Health Care industry group. From December 17, 2019 to December 3, 2025 it filed 3 private fundraising filings for 3 offerings and reported $85 million sold in all.

Updated November 11, 2026 · newest filing Dec 3, 2025

Amount sold

$85.0M

All offerings, newest filing of each

Offered

$182.5M

Total amount sought

Offerings

3

3 filings with amendments

Newest offering

$32.9M

Sold, first filed Dec 3, 2025

Investors

18

In the newest offering

Min. investment

-

In the newest offering

Facts

Type
Corporation
Place
San Diego, CA
Industry group
Other Health Care
Listed
No
First filing
December 17, 2019
Newest filing
December 3, 2025
Exemptions
506(b), 504, 4(a)(5)
Other names
Protego Biopharma

Amount sold by year

Each offering in the year of its first filing, at its newest amount sold

Amount sold by year

Offerings

3 offerings, newest first, each at its newest filing

First filedAmount soldOfferedInvestorsMin. investmentExemptionsSecurities
Dec 3, 2025$32.9M$130.4M18-506(b)Equity
Oct 28, 2021$51.0M$51.0M6-506(b)Equity
Dec 17, 2019$1.0M$1.0M3-504, 506(b), 4(a)(5)Equity, Options or warrants, Securities on exercise of options

Filing history

3 filings, newest first. An amendment updates an earlier offering.

FiledKindAmount soldOfferedInvestors
Dec 3, 2025New offering$32.9M$130.4M18
Oct 28, 2021New offering$51.0M$51.0M6
Dec 17, 2019New offering$1.0M$1.0M3

Related pages

Questions and answers

How much has Protego Biopharma, Inc. raised in private offerings?

$85 million sold in 3 private offerings reported from Dec 17, 2019 to Dec 3, 2025, counting each offering once at its newest filing.

When did Protego Biopharma, Inc. last file about a private offering?

December 3, 2025. Its newest offering reported $32.9 million sold of $130 million offered to 18 investors.

Which exemption does Protego Biopharma, Inc. use?

506(b), 504, 4(a)(5). Rule 506(b) does not allow public advertising.

Is Protego Biopharma, Inc. a listed company?

No ticker is linked to this issuer, so it is private or no longer listed.

These are notices that issuers file about their own private offerings, not verified results. Amounts are as stated in the filing. Official public data from private fundraising filings, updated daily. Amount sold is what the issuer had sold when it filed; the offered amount is the total it wants to raise.

More: Private Fundraising · Stock Screener · Industries

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube